Skip to main content

Currently Skimming:

1 Summary
Pages 1-4

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... To provide patients and their health care providers with adequate and reliable information about clinical trials that may be enroll ing patients.
From page 2...
... The committee's discussions also suggested that the next steps toward implementing a registry that accomplishes these goals would likely include the following: · Identification of uniform standards for data disclosure -- both at trial inception and for completed trials -- that apply to all entities conducting human clinical trials, whether privately or publicly funded. · Creation of a process that balances the interest in protecting con fidential and proprietary research data with the need to allow the broadest access possible to clinical trial information.
From page 3...
... The international pharmaceutical industry working withNLM has begun registering all but exploratory clinical trials on ClinicalTrials.gov, and providing the results of clinical trials on marketed products on ClinicalStudyResults.gov, an Internet database launched September 2004 by the Pharmaceutical Research and Manufacturers of America. The World Health Organization has finalized its position on global clinical trial registration and convened a group to develop a mechanism for advising on requests to delay release of one or more data items until a specified date.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.